154 related articles for article (PubMed ID: 9695145)
1. Morphine has a dual concentration-dependent effect on K(+)-evoked substance P release from rat peripheral airways.
Cabot PJ; Cramond T; Smith MT
Pulm Pharmacol Ther; 1997 Aug; 10(4):215-21. PubMed ID: 9695145
[TBL] [Abstract][Full Text] [Related]
2. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
Suarez-Roca H; Maixner W
J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
[TBL] [Abstract][Full Text] [Related]
3. Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes.
Suarez-Roca H; Maixner W
Brain Res; 1992 May; 579(2):195-203. PubMed ID: 1378347
[TBL] [Abstract][Full Text] [Related]
4. Morphine produces a biphasic modulation of substance P release from cultured dorsal root ganglion neurons.
Suarez-Roca H; Maixner W
Neurosci Lett; 1995 Jul; 194(1-2):41-4. PubMed ID: 7478208
[TBL] [Abstract][Full Text] [Related]
5. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
[TBL] [Abstract][Full Text] [Related]
6. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
7. [Behavioural studies during the gestational-lactation period in morphine treated rats].
Sobor M; Timár J; Riba P; Király KP; Al-Khrasani M; Gyarmati Z; Fürst Z
Neuropsychopharmacol Hung; 2013 Dec; 15(4):239-51. PubMed ID: 24380965
[TBL] [Abstract][Full Text] [Related]
8. The effects of pH on beta-endorphin and morphine inhibition of calcium transients in dorsal root ganglion neurons.
Vetter I; Kapitzke D; Hermanussen S; Monteith GR; Cabot PJ
J Pain; 2006 Jul; 7(7):488-99. PubMed ID: 16814688
[TBL] [Abstract][Full Text] [Related]
9. Morphine inhibits acid-sensing ion channel currents in rat dorsal root ganglion neurons.
Cai Q; Qiu CY; Qiu F; Liu TT; Qu ZW; Liu YM; Hu WP
Brain Res; 2014 Mar; 1554():12-20. PubMed ID: 24491633
[TBL] [Abstract][Full Text] [Related]
10. Multiphasic effect of morphine on the release of substance P from rat trigeminal nucleus slices.
Suarez-Roca H; Abdullah L; Zuniga J; Madison S; Maixner W
Brain Res; 1992 May; 579(2):187-94. PubMed ID: 1378346
[TBL] [Abstract][Full Text] [Related]
11. Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level.
Fu CY; Yang Q; Wang KR; Kong ZQ; Chen Q; Wang R
Behav Brain Res; 2006 Jun; 170(2):293-301. PubMed ID: 16621052
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
13. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
Iwamoto ET
Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
[TBL] [Abstract][Full Text] [Related]
14. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
Dong Z; Han H; Cao J; Xu L
Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
[TBL] [Abstract][Full Text] [Related]
15. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
16. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
Cicero TJ; Meyer ER; Miller BT; Bell RD
J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
[TBL] [Abstract][Full Text] [Related]
17. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
[TBL] [Abstract][Full Text] [Related]
18. Studies on the opiate receptor-mediated inhibition of K+-stimulated cholecystokinin and substance P release from cat hypothalamus in vitro.
Micevych PE; Yaksh TL; Go VL
Brain Res; 1984 Jan; 290(1):87-94. PubMed ID: 6198038
[TBL] [Abstract][Full Text] [Related]
19. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning of the rat random-pattern skin flap: modulation by opioids.
Kiumehr S; Demehri S; Rabbani S; Amanpour S; Mohagheghi MA; Dehpour AR
Br J Plast Surg; 2005 Jan; 58(1):58-64. PubMed ID: 15629168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
